1. A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients. (3rd December 2014) Authors: Brüggemann, R. J. M.; Van Der Velden, W. J. F. M.; Knibbe, C. A. J.; Colbers, A.; Hol, S.; Burger, D. M.; Donnelly, J. P.; Blijlevens, N. M. A. Journal: Journal of antimicrobial chemotherapy Issue: Volume 70:Number 4(2015:Apr.) Page Start: 1166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P12-59 Assessing the placental transfer of dexamethasone via ex vivo human placenta perfusions: a step-up towards model informeddrug dosing in pregnancy. (1st September 2022) Authors: van Hove, H.; van der Heijden, J.E.M.; van den Broek, P.; van Elst, N.; van Drongelen, J.; Colbers, A.; de Wildt, S.N.; Greupink, R. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Peg‐interferon and ribavirin treatment in HIV/HCV co‐infected patients in Thailand: efficacy, safety and pharmacokinetics. Issue 3 (10th January 2018) Authors: Smolders, E. J.; Thammajaruk, N.; de Kanter, C. T. M. M.; Colbers, A.; Chaiyahong, P.; Cuprasitrut, T.; Chittmittraprap, S.; Apornpong, T.; Khemnark, S.; Tangkijvanich, P.; Burger, D. M.; Avihingsanon, A. Journal: Tropical medicine & international health Issue: Volume 23:Issue 3(2018) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review. (May 2022) Authors: van Hove, H.; Mathiesen, L.; Freriksen, J.J.M.; Vähäkangas, K.; Colbers, A.; Brownbill, P.; Greupink, R. Journal: Placenta Issue: Volume 122(2022) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗